This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In
It’s rare to get such a massive high-yielder that’s also positioning itself for long-term growth. Of course, shares of Pfizer (NYSE:PFE | PFE Price Prediction) have faced immense challenges in the years…